ReviewJournal of experimental pharmacology2026
Exploratory Review on Male Fertility Potential of Acetyl-Eugenol: Mechanistic Insights, Experimental Evidence, and Therapeutic Prospects.
Review in Journal of experimental pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Male infertility contributes to nearly half of all infertility cases worldwide and is closely linked to oxidative stress, inflammation, endocrine imbalance, and environmental toxicant exposure, all of which impair spermatogenesis and sperm function. Interest in naturally derived bioactive compounds has increased due to their potential multitarget therapeutic effects and relatively favorable safety profiles. Acetyl-eugenol, a structural derivative of eugenol found in Syzygium aromaticum and other aromatic plants, has demonstrated antioxidant, anti-inflammatory, and cytoprotective activities in experimental studies. This review critically evaluates the potential role of acetyl-eugenol in male reproductive health, focusing on its pharmacological properties and proposed mechanisms of action. Available preclinical evidence suggests that acetyl-eugenol may reduce oxidative stress by scavenging reactive oxygen species, enhancing endogenous antioxidant defenses, and modulating inflammatory pathways such as NF-κB signaling. It may also contribute to the preservation of testicular structure and function, including protection of Sertoli and Leydig cells. However, current evidence remains limited and is derived predominantly from in vitro and animal studies, with very limited direct evidence in humans. Many proposed reproductive benefits are inferred from studies involving eugenol or related compounds rather than acetyl-eugenol specifically. In addition, conflicting findings regarding dose-dependent toxicity, insufficient pharmacokinetic data, and the absence of standardized clinical studies limit definitive conclusions regarding efficacy and safety. Overall, acetyl-eugenol represents a promising candidate for mitigating oxidative stress-associated male reproductive dysfunction, but its therapeutic potential remains preliminary. Further well-designed experimental and clinical studies are necessary to clarify its mechanisms, safety profile, and translational relevance in male infertility management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.